A case of Muir-Torre syndrome

Abstract


A case of Muir-Torre syndrome is described, which manifested with a combination of skin tumors (keratoakantoma, adenoms or cancer of sebaceous glands and neoplasia of internal organs). Most often gastrointestinal tract and urogenital system are affected. Authors present a case of persistent giant keratoacantoma, sebaceous adenomas and prostate adenocarcinoma in a patient. Sebaceous tumors are the obligatory marker of Muir-Torre syndrome, that is why it is important to look for internal neoplasia after the detection of these tumours.

References

  1. Молочков В. А., Казанцева И. А., Кунцевич Ж. С., Бочкарева Е. В. Кератоакантома. Клиника, диагностика, лечение, трансформация в рак. - М.: Бином; 2006.
  2. Cohen P. R., Kohn S. R., Kurzrock R. // Am. J. Med. - 1991. - Vol. 90. - P. 606-613.
  3. Graells J., Marcoval M., Badell A. et al. // Br. J. Dermatol. - 1996. - Vol. 135. - P. 159-161.
  4. Hartig C., Stieler W., Studler R. // Hautarzt. - 1995. - Bd 46. - S. 107-113.
  5. Matthews J. J., Roberts R., O'Reilly D. A. et al. // Dig. Surg. - 2002. - Vol. 19. - P. 65-66.
  6. Rothenberg J., Lambert W. C., Vail J. T. Jr. et al. // J. Am. Acad. Dermatol. - 1990. - Vol. 23. - P. 638-640.
  7. Schwartz R. A. // J. Am. Acad. Dermatol. - 1994. - Vol. 30. - P. 1-19.
  8. Schwartz R. A., Torre D. P. // J. Am. Acad. Dermatol. - 1995. - Vol. 33. - P. 90-104.
  9. Spraul C. W., Lang G. E., Grossniklaus H. E., Lung G. K. // Am. J. Ophthalmol. - 1995. - Vol. 120. - P. 248-250.
  10. Stone M. S., Duncan W. C., Mc Garvan M. H. // J. Am. Acad. Dermatol. - 1986. - Vol. 15. - P. 1101-1103.

Statistics

Views

Abstract - 21

Cited-By


Article Metrics

Metrics Loading ...

PlumX

Dimensions


Copyright (c) 2020 Molochkov V.A., Kuntsevich Z.S., Khlebnikova A.N., Vlasova M.A., Bochkareva E.V., Lavrov D.B., Molochkov V.A., Kuncevich Z.S., Khlebnikova A.N., Vlasova M.A., Bochkareva E.V., Lavrov D.B.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies